NBD AI Bulletin -- Jinyu Bio-Technology Co., Ltd. (the Company, SH 600201, closing price: 25.78 yuan) released its earnings report on October 22. For the first three quarters of 2020, revenue comes in at about 1.108 billion yuan, an increase of 30.65% year on year; Net profit stands at about 296 million yuan, an increase of 19.03% year on year; Basic earnings per share is 0.26 yuan, an increase of 18.18% year on year. 

The Company's 2019 annual report shows that Jinyu Bio-Technology Co., Ltd. mainly engages in biopharmaceuticals and other, accounting for 95.6% and 3.77% of its revenue, respectively.

Jinyu Bio-Technology Co., Ltd.'s chairman is Zhang Chongyu, male, 66 years old, with a master's degree, senior economist. The Company's president is Zhang Jing, female, 37 years old, with a master's degree.

Tips on "Stock Trends":

1. The number of shares held by northbound investors decreased by 1.8463 million in the past 30 days, representing 0.16% of the Company's circulating shares. 

2. There was no institutional research on the Company in the past 30 days. 

(By Tan Yuhan)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.